Wenwu Xue
机构：Shantou University, Cancer Hospital of Shantou University Medical College
发表论文 9 篇 · 总被引 25 次 · h-index 3
代表论文
- Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma (2024 · Scientific Reports · 被引 13)
- Machine learning based immune evasion signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma (2025 · Frontiers in Cell and Developmental Biology · 被引 4)
- Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancer (2025 · Scientific Reports · 被引 4)
- Human endogenous retrovirus ERVK3-1 characterizes a metabolically active and immunosuppressive subtype of liver cancer (2025 · Virology Journal · 被引 2)
- Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report (2025 · Frontiers in Immunology · 被引 1)
- Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights (2025 · Frontiers in Oncology · 被引 1)